Home Casteddu.com	FAQ My Amedeo About	Flying Publisher
	The Medical Article of the Year 2008: Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007; 447:661-78. Free full-text

Bladder Cancer

Free Subscription Articles published in J Clin Oncol Retrieve available abstracts of 24 articles: HTML format

Single Articles

May 2008
1. BLANCHARD CM , Courneya KS, Stein K
   Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II.
   J Clin Oncol. 2008;26:2198-204.
   PubMed     Related articles    Abstract available
   
   
   January 2008
2. BONNIN N , El Karak F, Droz JP, Flechon A, et al
   Pleural metastasis in a patient with bladder cancer.
   J Clin Oncol. 2008;26:329-30.
   PubMed     Related articles   
   
   
   
3. KASSOUF W , Agarwal PK, Herr HW, Munsell MF, et al
   Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
   J Clin Oncol. 2008;26:121-6.
   PubMed     Related articles    Abstract available
   
   
   December 2007
4. GEORGE B , Datar RH, Wu L, Cai J, et al
   p53 gene and protein status: the role of p53 alterations in predicting outcome in patients with bladder cancer.
   J Clin Oncol. 2007;25:5352-8.
   PubMed     Related articles    Abstract available
   
   
   
5. REAL FX
   p53: it has it all, but will it make it to the clinic as a marker in bladder cancer?
   J Clin Oncol. 2007;25:5341-4.
   PubMed     Related articles   
   
   
   November 2007
6. GLYNNE-JONES R , Hoskin P
   Neoadjuvant cisplatin chemotherapy before chemoradiation: a flawed paradigm?
   J Clin Oncol. 2007;25:5281-6.
   PubMed     Related articles    Abstract available
   
   
   
7. WU X , Lin J, Grossman HB, Huang M, et al
   Projecting individualized probabilities of developing bladder cancer in white individuals.
   J Clin Oncol. 2007;25:4974-81.
   PubMed     Related articles    Abstract available
   
   
   September 2007
8. LIN WC , Chen JH
   Urinary bladder metastasis from breast cancer with heterogeneic expression of estrogen and progesterone receptors.
   J Clin Oncol. 2007;25:4308-10.
   PubMed     Related articles   
   
   
   June 2007
9. BIVALACQUA TJ , Alphs H, Aksentijevich I, Schaeffer EM, et al
   Paraneoplastic polyarthritis from non-small-cell lung cancer metastatic to the bladder.
   J Clin Oncol. 2007;25:2621-3.
   PubMed     Related articles   
   
   
   
10. VAUGHN DJ
    Moving forward in advanced bladder cancer.
    J Clin Oncol. 2007;25:2162-3.
    PubMed     Related articles   
    
    
    
11. HUSSAIN MH , MacVicar GR, Petrylak DP, Dunn RL, et al
    Trastuzumab, paclitaxel, carboplatin, and gemcitabine in advanced human epidermal growth factor receptor-2/neu-positive urothelial carcinoma: results of a multicenter phase II National Cancer Institute trial.
    J Clin Oncol. 2007;25:2218-24.
    PubMed     Related articles    Abstract available
    
    
    December 2006
12. MITRA AP , Datar RH, Cote RJ
    Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
    J Clin Oncol. 2006;24:5552-64.
    PubMed     Related articles    Abstract available
    
    
    
13. GARCIA JA , Dreicer R
    Systemic chemotherapy for advanced bladder cancer: update and controversies.
    J Clin Oncol. 2006;24:5545-51.
    PubMed     Related articles    Abstract available
    
    
    
14. RODEL C , Weiss C, Sauer R
    Trimodality treatment and selective organ preservation for bladder cancer.
    J Clin Oncol. 2006;24:5536-44.
    PubMed     Related articles    Abstract available
    
    
    
15. PAREKH DJ , Bochner BH, Dalbagni G
    Superficial and muscle-invasive bladder cancer: principles of management for outcomes assessments.
    J Clin Oncol. 2006;24:5519-27.
    PubMed     Related articles    Abstract available
    
    
    
16. BLACK PC , Brown GA, Dinney CP
    Molecular markers of urothelial cancer and their use in the monitoring of superficial urothelial cancer.
    J Clin Oncol. 2006;24:5528-35.
    PubMed     Related articles    Abstract available
    
    
    August 2006
17. HERNANDEZ S , Lopez-Knowles E, Lloreta J, Kogevinas M, et al
    Prospective study of FGFR3 mutations as a prognostic factor in nonmuscle invasive urothelial bladder carcinomas.
    J Clin Oncol. 2006;24:3664-71.
    PubMed     Related articles    Abstract available
    
    
    July 2006
18. 
    Postoperative Nomogram Predicting Risk of Recurrence After Radical Cystectomy for Bladder Cancer.
    J Clin Oncol. 2006;.
    PubMed     Related articles    Abstract available
    
    
    
19. STERNBERG CN
    Bladder Cancer: Are Nomograms Better Than Currently Available Stage Groupings?
    J Clin Oncol. 2006;.
    PubMed     Related articles   
    
    
    
20. SWEENEY CJ , Roth BJ, Kabbinavar FF, Vaughn DJ, et al
    Phase II study of pemetrexed for second-line treatment of transitional cell cancer of the urothelium.
    J Clin Oncol. 2006;24:3451-7.
    PubMed     Related articles    Abstract available
    
    
    
21. RAJ GV , Iasonos A, Herr H, Donat SM, et al
    Formulas calculating creatinine clearance are inadequate for determining eligibility for Cisplatin-based chemotherapy in bladder cancer.
    J Clin Oncol. 2006;24:3095-100.
    PubMed     Related articles    Abstract available
    
    
    
22. MCKIERNAN JM , Masson P, Murphy AM, Goetzl M, et al
    Phase I trial of intravesical docetaxel in the management of superficial bladder cancer refractory to standard intravesical therapy.
    J Clin Oncol. 2006;24:3075-80.
    PubMed     Related articles    Abstract available
    
    
    June 2006
23. DALBAGNI G , Russo P, Bochner B, Ben-Porat L, et al
    Phase II trial of intravesical gemcitabine in bacille Calmette-Guerin-refractory transitional cell carcinoma of the bladder.
    J Clin Oncol. 2006;24:2729-34.
    PubMed     Related articles    Abstract available
    
    
    May 2006
24. WEISS C , Wolze C, Engehausen DG, Ott OJ, et al
    Radiochemotherapy After Transurethral Resection for High-Risk T1 Bladder Cancer: An Alternative to Intravesical Therapy or Early Cystectomy?
    J Clin Oncol. 2006;24:2318-2324.
    PubMed     Related articles    Abstract available
    
    

Thank you for your interest in scientific medicine.

Amedeo is a Bernd Sebastian Kamps website.    Design: